Journal article · 2018 · Open access

From guideline to practice: New shared decision‐making tools for colorectal cancer screening from the American Cancer Society

Robert Joseph Volk, Viola B. Leal, Lianne E. Jacobs, Andrew M. D. Wolf, Durado D. Brooks, Richard C. Wender, Robert Allen Smith

CA A Cancer Journal for Clinicians, 68(4), 246–249 · Published 30 May 2018 · DOI 10.3322/caac.21459

Open PDFView at the publisherCite this paper

In brief

“From guideline to practice: New shared decision‐making tools for colorectal cancer screening from the American Cancer Society” is a 2018 journal article by Robert Joseph Volk and 6 co-authors, published in CA A Cancer Journal for Clinicians. OpenAlex counts 49 citations as of 21 November 2026, which puts it in the top 9% of works published in 2018 by citations. It is open access: the full text is free to read at CA A Cancer Journal for Clinicians.

Citations
49
Most cited in
2019 (10)
Field-weighted impact
2.34
References
22
Authors
7

Abstract

The goal of the American Cancer Society (ACS) 2018 guideline update for colorectal cancer (CRC) screening is to reduce the incidence of and deaths from CRC for average-risk adults aged 45 years and older through the use of screening tests that are selected to align with a patient's preferences and test availability.1 Beginning screening at age 45 years is a qualified recommendation, and regular screening of adults aged 50 years and older is a strong recommendation. The basis for the grading of these recommendations is described in the guideline update.1 For adults in good health with at least a 10-year life expectancy, screening should continue to age 75 years, whereas the decision to screen individuals ages 76 through 85 years should be individualized based on patient preferences, life expectancy, health status, and prior screening history (qualified recommendation). Clinicians should discourage individuals older than 85 years from continuing screening (qualified recommendation). The updated guideline includes details about the process for developing and rating the recommendations.1 In the updated guideline, the ACS Guideline Development Group placed greater emphasis on the importance of patient preferences and choice in selecting a screening test, with the goal of increasing CRC screening uptake and adherence. Six screening options are included in the new guideline, including 3 stool-based tests (fecal immunochemical test [FIT]; high-sensitivity guaiac-based fecal occult blood test [HSgFOBT]; and multitarget stool DNA test [mt-sDNA]) and 3 structural (visual) examinations (colonoscopy, computed tomography colonography [CTC], and flexible sigmoidoscopy [FS]). Each option is associated with unique operational and performance attributes as well as demands on patients, and there is an extensive literature demonstrating variability in how patients value the attributes of CRC screening options.2-5 These attributes, which include the frequency of testing, test procedures, and required preparation, alone or in combination, can impact a patient's preference for CRC screening tests.3 Provider recommendations also strongly influence the uptake of screening and choice of test.6 Decision making about CRC screening therefore involves the patient weighing the importance of the test attributes when making a decision with a health care provider about which test is right for them. In the absence of the provider's assessment of patient preferences, screening may not take place if the test offered is judged by the patient to be undesirable. There is evidence that screening intentions are higher among patients who are offered an option that is consonant with their preferences.5, 7 The updated guideline emphasizes the importance of communication about CRC screening between health care providers and patients to improve CRC screening utilization.8 Shared…

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Volk, R. J., Leal, V. B., Jacobs, L. E., Wolf, A. M. D., Brooks, D. D., Wender, R. C., & Smith, R. A. (2018). From guideline to practice: New shared decision‐making tools for colorectal cancer screening from the American Cancer Society. CA A Cancer Journal for Clinicians, 68(4), 246–249. https://doi.org/10.3322/caac.21459

MLA 9

Volk, Robert Joseph, et al. “From guideline to practice: New shared decision‐making tools for colorectal cancer screening from the American Cancer Society.” CA A Cancer Journal for Clinicians, vol. 68, no. 4, 2018, pp. 246–249. https://doi.org/10.3322/caac.21459.

Chicago

Volk, Robert Joseph, Viola B. Leal, Lianne E. Jacobs, Andrew M. D. Wolf, Durado D. Brooks, Richard C. Wender, and Robert Allen Smith. 2018. “From guideline to practice: New shared decision‐making tools for colorectal cancer screening from the American Cancer Society.” CA A Cancer Journal for Clinicians 68 (4): 246–249. https://doi.org/10.3322/caac.21459.

Harvard

Volk, R. J. et al. (2018) ‘From guideline to practice: New shared decision‐making tools for colorectal cancer screening from the American Cancer Society’, CA A Cancer Journal for Clinicians, 68(4), pp. 246–249. doi:10.3322/caac.21459.

IEEE

R. J. Volk et al., “From guideline to practice: New shared decision‐making tools for colorectal cancer screening from the American Cancer Society,” CA A Cancer Journal for Clinicians, vol. 68, no. 4, pp. 246–249, 2018, doi: 10.3322/caac.21459.

BibTeX

@article{volk2018from,
  title     = {{From guideline to practice: New shared decision‐making tools for colorectal cancer screening from the American Cancer Society}},
  author    = {Volk, Robert Joseph and Leal, Viola B. and Jacobs, Lianne E. and Wolf, Andrew M. D. and Brooks, Durado D. and Wender, Richard C. and Smith, Robert Allen},
  journal   = {CA A Cancer Journal for Clinicians},
  year      = {2018},
  volume    = {68},
  number    = {4},
  pages     = {246--249},
  doi       = {10.3322/caac.21459},
  url       = {https://doi.org/10.3322/caac.21459}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201833
20191010
202066
202166
202277
202355
202433
202555
202644

Its field-weighted citation impact is 2.34: it has been cited 2.34 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection

  • shared decision-making
  • colorectal cancer screening
  • patient preferences
  • screening test selection
  • fecal immunochemical test
  • multi-target stool DNA test
  • colonoscopy
  • computed tomography colonography

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Volk, R. J., Leal, V. B., Jacobs, L. E., Wolf, A. M. D., Brooks, D. D., Wender, R. C., & Smith, R. A. (2018). From guideline to practice: New shared decision‐making tools for colorectal cancer screening from the American Cancer Society. CA A Cancer Journal for Clinicians, 68(4), 246–249. https://doi.org/10.3322/caac.21459

How many times has this paper been cited?

49 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at CA A Cancer Journal for Clinicians: sign in and open the PDF from this page.

Who wrote this paper?

Robert Joseph Volk, Viola B. Leal, Lianne E. Jacobs, Andrew M. D. Wolf, Durado D. Brooks, Richard C. Wender, Robert Allen Smith.

What is the DOI of this paper?

10.3322/caac.21459, permanently at https://doi.org/10.3322/caac.21459. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.